Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Orebro – page 6

142 clinical trials in Orebro, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Orebro at a glance
142
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

142 trials in Orebro

Open in trial search

Prostate cancer recurrent

Recruiting

Study Comparing Conventional Radiotherapy and PSMA-PET/CT Targeted Treatment with 18F-PSMA-1007 and Gozetotide for Prostate Cancer Recurrence After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Karolinska University Hospital

Atrial fibrillation

Recruiting

Study on Stopping Anticoagulants in Atrial Fibrillation Patients After Surgery: Warfarin, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, and Drug Combination

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Odense University Hospital

Cardiac ablation

Recruiting

Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Dronedarone
  • Sponsor:Gottsegen National Cardiovascular Center

Ectopic pregnancy

Recruiting

Study on Mifepristone and Letrozole for Treating Ectopic Pregnancy in Comparison to Methotrexate

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Letrozole
  • Sponsor:Karolinska Institutet

Brain abscess

Recruiting

Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Aalborg University Hospital

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Acute lymphocytic leukaemia

Recruiting

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Metapneumovirus infection

Not yet recruiting

Study on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Human metapneumovirus, virus-like protein
  • Sponsor:AstraZeneca AB

Anaemia+1

Not yet recruiting

Study of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Dementia Alzheimer's type

Not yet recruiting

A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

Investigational
Countries:SwedenSweden
  • Participants:65+ years

Palliative care

Not yet recruiting

Morphine Hydrochloride for Resting Breathlessness in Adults with Serious Chronic Life‑Limiting Disease Receiving Palliative Care

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Skane

Schizophrenia

Not yet recruiting

Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Rituximab
  • Sponsor:Region Oerebro Laen

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Orebro

What the registry says about research in the country

01 Infectious Diseases & Vaccines

Clinical trials focusing on preventive vaccines against respiratory syncytial virus, Human Metapneumovirus, and Herpes Zoster in older adults. Studies evaluate vaccine efficacy, immune response, and safety profiles.

  • RSV and hMPV Prevention
  • Herpes Zoster Protection
  • HPV Infection Control
02 Metabolic Disorders

Research examining treatments for obesity and Type 2 diabetes. Studies evaluate new therapeutic approaches combining medication with lifestyle modifications for weight management.

  • Weight Management
  • Diabetes Control
  • Cardiovascular Risk Management
03 Oncology

Innovative trials in chronic lymphocytic leukemia, breast cancer, and other malignancies. Studies explore novel treatment combinations and personalized approaches for better patient outcomes.

  • Leukemia Treatment
  • Breast Cancer Therapy
  • Cancer-related Depression
Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.